Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responsesMohamad‐Gabriel Alameh, Norbert Pardi, Benjamin Davis et al.|Immunity|2021Cited by 713
TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate DecisionZeyu Chen, E. John Wherry, Zhicheng Ji et al.|Immunity|2019Cited by 703
Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisSusan E. Dorman, Richard E. Chaisson, Payam Nahid et al.|New England Journal of Medicine|2021Cited by 548
Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary TuberculosisWilliam J. Burman, Richard E. Chaisson, Stefan Goldberg et al.|American Journal of Respiratory and Critical Care Medicine|2006Cited by 285
Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary TuberculosisSusan E. Dorman, Richard E. Chaisson, John L. Johnson et al.|American Journal of Respiratory and Critical Care Medicine|2009Cited by 266